Search research articles
Contact Us
Filters
Showing results (371-380 of 376) with videos related to
Page
of 38
Sort By:
You have reached the last page of results.
This site can display upto 376 results.
Frontiers in Immunology
|
April 7, 2022
Baseline Inflammatory Status Reveals Dichotomic Immune Mechanisms Involved In Primary-Progressive Multiple Sclerosis Pathology
José I Fernández-Velasco, Enric Monreal, Jens Kuhle, et al.
Neurologia
|
January 29, 2020
Consensus statement on the use of alemtuzumab in daily clinical practice in Spain
J E Meca-Lallana, M Fernández-Prada, E García Vázquez, et al.
Neurologia
|
October 4, 2022
Consensus statement on the use of alemtuzumab in daily clinical practice in Spain
J E Meca-Lallana, M Fernández-Prada, E García Vázquez, et al.
Journal of Clinical Medicine
|
December 9, 2023
Seroprevalence of SARS-CoV-2 in Patients with Multiple Sclerosis under Disease-Modifying Therapies: A Multi-Centre Study
Agustín Sancho-Saldaña, Anna Gil-Sánchez, Cristina González-Mingot, et al.
BMC Musculoskeletal Disorders
|
April 11, 2008
Psychometric characteristics of the Spanish version of instruments to measure neck pain disability
Francisco M Kovacs, Joan Bagó, Ana Royuela, et al.
Brain : a Journal of Neurology
|
August 5, 2024
Serum biomarkers at disease onset for personalized therapy in multiple sclerosis
Enric Monreal, José Ignacio Fernández-Velasco, Roberto Álvarez-Lafuente, et al.
Page
of 38
Search research articles
Search
Showing results (371-380 of 376) with videos related to
Sort By:
Page
of 38
You have reached the last page of results.
This site can display upto 376 results.
Frontiers in Immunology
|
April 7, 2022
Baseline Inflammatory Status Reveals Dichotomic Immune Mechanisms Involved In Primary-Progressive Multiple Sclerosis Pathology
José I Fernández-Velasco, Enric Monreal, Jens Kuhle, et al.
Neurologia
|
January 29, 2020
Consensus statement on the use of alemtuzumab in daily clinical practice in Spain
J E Meca-Lallana, M Fernández-Prada, E García Vázquez, et al.
Neurologia
|
October 4, 2022
Consensus statement on the use of alemtuzumab in daily clinical practice in Spain
J E Meca-Lallana, M Fernández-Prada, E García Vázquez, et al.
Journal of Clinical Medicine
|
December 9, 2023
Seroprevalence of SARS-CoV-2 in Patients with Multiple Sclerosis under Disease-Modifying Therapies: A Multi-Centre Study
Agustín Sancho-Saldaña, Anna Gil-Sánchez, Cristina González-Mingot, et al.
BMC Musculoskeletal Disorders
|
April 11, 2008
Psychometric characteristics of the Spanish version of instruments to measure neck pain disability
Francisco M Kovacs, Joan Bagó, Ana Royuela, et al.
Brain : a Journal of Neurology
|
August 5, 2024
Serum biomarkers at disease onset for personalized therapy in multiple sclerosis
Enric Monreal, José Ignacio Fernández-Velasco, Roberto Álvarez-Lafuente, et al.
Page
of 38